Kontafarma China Holdings Ltd (HK:1312) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Kontafarma China Holdings Limited has announced that its Board of Directors will convene on August 28, 2024, to review and approve the subsidiary’s interim financial results for the first half of the year and to discuss the potential distribution of an interim dividend. The upcoming board meeting is set to shape the company’s financial strategies moving forward. This announcement was made by Chairman Wang Feifei on behalf of the company.
For further insights into HK:1312 stock, check out TipRanks’ Stock Analysis page.